Medical Market Report

Global Mrna Vaccines & Therapeutics Market By Type (Standardization Of Cancer Treatment Mrna Vaccine, Individualized Cancer Treatment Mrna Vaccine, Infectious Disease Treatment Mrna Vaccine, And Infection Prevention Mrna Vaccine), By Application (Infectious Disease, Cancer, And Other), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2020-2029

  • 135391
  • 16-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on mRNA Vaccines & Therapeutics Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global mrna vaccines & therapeutics market is segmented on the basis of Type, Application, and geography. The worldwide market for mRNA Vaccines & Therapeutics Market is expected to grow at a CAGR of roughly x.x% over the next ten years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    mRNA Vaccines & Therapeutics Market Scope:

    By type, the market is segmented into Standardization Of Cancer Treatment MRNA Vaccine, Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine, and Infection Prevention MRNA Vaccine. By Application, the market is divided into Infectious Disease, Cancer, and Other.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, and Tiba Biotechnology

    .

    Key Market Segments

    Type

    Standardization Of Cancer Treatment MRNA Vaccine
    Individualized Cancer Treatment MRNA Vaccine
    Infectious Disease Treatment MRNA Vaccine
    Infection Prevention MRNA Vaccine

    Application

    Infectious Disease
    Cancer
    Other

    Key Market Players included in the report:

    Moderna Therapeutics
    CureVac
    Translate Bio
    BioNTech
    Sangamo Therapeutics
    Argos Therapeutics
    In-Cell-Art
    eTheRNA
    Ethris
    Tiba Biotechnology

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and mRNA Vaccines & Therapeutics Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of mRNA Vaccines & Therapeutics Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers mRNA Vaccines & Therapeutics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global mRNA Vaccines & Therapeutics Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the mRNA Vaccines & Therapeutics Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the mRNA Vaccines & Therapeutics Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of mRNA Vaccines & Therapeutics sub-markets, depending on key regions (various vital states).
    To analyze mRNA Vaccines & Therapeutics Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the mRNA Vaccines & Therapeutics Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide mRNA Vaccines & Therapeutics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. mRNA Vaccines & Therapeutics Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global mRNA Vaccines & Therapeutics Market Overview
    

    3.1. mRNA Vaccines & Therapeutics Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global mRNA Vaccines & Therapeutics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global mRNA Vaccines & Therapeutics Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. Standardization Of Cancer Treatment MRNA Vaccine
    
4.4. Individualized Cancer Treatment MRNA Vaccine
    
4.5. Infectious Disease Treatment MRNA Vaccine
    
4.6. Infection Prevention MRNA Vaccine5. Global mRNA Vaccines & Therapeutics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global mRNA Vaccines & Therapeutics Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Infectious Disease
    
5.4. Cancer
    
5.5. Other6. Global mRNA Vaccines & Therapeutics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America mRNA Vaccines & Therapeutics Market: Regional Trend Analysis
    

    6.1.1.1. US
    
6.1.1.2. Canada
    
6.1.1.3. Mexico
    

    6.2.1. Europe
    

    6.2.1. Europe mRNA Vaccines & Therapeutics Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Spain
    
6.2.1.7. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific mRNA Vaccines & Therapeutics Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4. India
    
6.3.1.5. Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America mRNA Vaccines & Therapeutics Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa mRNA Vaccines & Therapeutics Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global mRNA Vaccines & Therapeutics Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. Moderna Therapeutics
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. CureVac
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Translate Bio
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments7.6. BioNTech
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. Sangamo Therapeutics
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. Argos Therapeutics
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. In-Cell-Art
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7.10. eTheRNA
    

    7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments7.11. Ethris
    

    7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments7.12. Tiba Biotechnology
    

    7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.